A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABBV-1088 Oral Dose in Healthy Adult Participants.

Completed · Phase 1 · Has a placebo group

Conditions studied: Healthy Volunteers

In brief

This study will assess the single dose safety, tolerability and pharmacokinetic properties of ABBV-1088 in healthy adult participants

Key facts

Study ID
NCT06414798
Run by
AbbVie
People needed
60
Starts
2024-05-13
Expected to finish
2025-02-08
Last updated by the study team
2025-02-19

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.